XML 44 R33.htm IDEA: XBRL DOCUMENT v3.21.2
COMMON STOCK PURCHASE WARRANTS (Tables)
6 Months Ended
Jun. 30, 2021
Common Stock Purchase Warrants  
SCHEDULE OF FAIR VALUE OF THE WARRANT DERIVATIVE LIABILITIES

The Company has utilized the following assumptions in its Black-Scholes option valuation model to calculate the estimated fair value of the warrant derivative liabilities as of their date of issuance and as of June 30, 2021:

 

   Issuance date assumptions   June 30, 2021 assumptions 
Volatility - range   106.6166.6%   107.5%
Risk-free rate   0.08 - 0.49%   0.87%
Dividend   0%   0%
Remaining contractual term   0.01 - 5 years    4.6 years 
Exercise price  $2.80 - 3.25   $3.25 
Common stock issuable under the warrants   42,550,000    24,300,000 
SUMMARY OF WARRANT ACTIVITY

The following table summarizes information about shares issuable under warrants outstanding during the six months ended June 30, 2021:

 

   Warrants  

Weighted

average

exercise price

 
Vested Balance, January 1, 2021   3,388,364   $6.24 
Granted   42,550,000    3.11 
Exercised   (18,250,000)   2.92 
Forfeited/cancelled   (879,766)   13.43 
Vested Balance, June 30, 2021   26,808,598   $3.29 
SUMMARY OF RANGE OF EXERCISE PRICES AND WEIGHTED AVERAGE REMAINING CONTRACTUAL LIFE OF WARRANTS

The following table summarizes the range of exercise prices and weighted average remaining contractual life for outstanding and exercisable warrants to purchase shares of common stock as of June 30, 2021:

 

     Outstanding and exercisable warrants
 Exercise price    Number of warrants 

Weighted average

remaining

contractual life

$2.60    465,712  2.1 years
$3.00    316,800  1.8 years
$3.25    24,300,000  4.6 years
$3.36    733,333  1.4 years
$3.65    167,000  1.0 years
$3.75    25,753  1.1 years
$5.00    800,000  0.5 years
         
      26,808,598  4.3 years